Bionano Genomics, Inc. Gains 133.77%
Mon, Jan 04, 2021 at 05:30 PM
Bionano Genomics, Inc. (BNGO:NASDAQ) soared at $7.2, a gain of 133.8%. The stock appeared on our News Catalysts scanner on Wed 30 Dec 20 at 10:36 AM in the 'PRIVATE PLACEMENT' category. From Thu 17 Dec 20, the stock recorded 77.78% Up Days and 60.00% Green Days
About Bionano Genomics, Inc. (BNGO:NASDAQ)
Bionano Genomics Inc is a life sciences instrumentation company in the genome analysis space. It is engaged in the development and marketing of the Saphyr system, a platform for ultra-sensitive and ultra-specific structural variation detection that enables researchers and clinicians to accelerate the search for new diagnostics and therapeutic targets and to streamline the study of changes in chromosomes.
Top 10 Gainers:
- Check-Cap Ltd. (CHEK:NASDAQ), 215.22%
- Bionano Genomics, Inc. (BNGO:NASDAQ), 133.77%
- Jaguar Health, Inc. (JAGX:NASDAQ), 118.4%
- TransEnterix, Inc. (TRXC:NYSEMKT), 87.2%
- The9 Limited (NCTY:NASDAQ), 87.01%
- ViewRay, Inc. (VRAY:NASDAQ), 67.8%
- Ocugen, Inc. (OCGN:NASDAQ), 67.76%
- Zomedica Pharmaceuticals Corp. (ZOM:NYSEMKT), 51.78%
- PAND (PAND:NASDAQ), 47.74%
- KSPN (KSPN:NASDAQ), 39.23%